Clinical Trial Update: The Role of Leptin Receptors in NASH

View source ↗

Summary

This clinical trial evaluated the role of leptin receptors in nonalcoholic steatohepatitis (NASH) and metabolic syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: University of California, Davis | Conditions: Nonalcoholic Steatohepatitis, Metabolic Syndrome | Status: COMPLETED